![Robert Felsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Robert Felsch worked as the Controller & Vice President-Finance at Ardelyx, Inc. from 2020 to 2021.
He then served as the Senior Vice President & Controller at IGM Biosciences, Inc. from 2021 to 2022.
Following that, he held the position of Chief Accounting Officer & Senior VP-Finance at Ardelyx, Inc. from 2022 to 2024.
Mr. Felsch completed his undergraduate degree at the University of Southern California.
Former positions of Robert Felsch
| Companies | Position | End |
|---|---|---|
| ARDELYX, INC. | Comptroller/Controller/Auditor | 14/11/2024 |
| IGM BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 31/12/2021 |
| ARDELYX, INC. | Comptroller/Controller/Auditor | 31/08/2021 |
Training of Robert Felsch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
- Stock Market
- Insiders
- Robert Felsch
